Business Services Industry

Japanese Chemical Company to Fund Disease Research at Boston Medical Center.

Knight Ridder/Tribune Business News, January, 2003

By Jeffrey Krasner, The Boston Globe Knight Ridder/Tribune Business News

Jan. 10--Takeda Chemical Industries Ltd. of Japan will pay $13.7 million over three years to fund research at Beth Israel Deaconess Medical Center looking at the molecular causes of metabolic diseases including diabetes and obesity, the hospital said yesterday.

The deal, one of the largest industry-sponsored research projects at a local teaching hospital in recent years, is intended to develop treatments for diabetes and obesity. Takeda, Japan's largest pharmaceutical firm, will have an exclusive option to negotiate licenses to any drug candidates developed. The agreement could be extended by two years with funding reaching $25 million.

The two organizations...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement